The nation of Zimbabwe has turned down a major US health deal valued at $367m (£272m) over five years because of Washington's demand for sensitive biological samples.
This rejection was revealed after a internal memorandum dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".
A government spokesman later explained that the United States was requesting biological samples for research and commercial purposes but was not willing to share the benefits from future medical innovations.
"We are forced to start the difficult and regrettable task of scaling back our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had furnished more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has called for continued negotiations to find a deal suitable to all parties so the country's vital HIV treatment initiative can continue.
Wider Background
Zimbabwe's decision comes after a similar situation in Kenya, where a court halted a related health funding agreement following concerns were filed about the security of Kenyans' health data.
Since resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the US government, but Trump claimed its expenditure was "wasteful" and his administration was seeking government-to-government deals to boost openness and accountability.
According to reports, Sixteen nations in Africa have to date signed similar health pacts, constituting over $18.3bn in new funding.
Details of the Rejected Deal
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy through American-funded programmes," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Zimbabwe was being asked to share its genetic material and health information for a long time, without any equivalent promise of access to any medical innovations – like new medicines or tests – that could result from that provided information," he stated.
"In essence, our nation would provide the basic resources for scientific discovery with no certainty that the end products would be available to our population if a future pandemic emerge."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were upending structures already set up through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system created to deal with future global health emergencies.
"This system is designed to guarantee that when a country contributes its data, the benefits – including medicines and cures – are distributed fairly, not commercialised solely by those with the capability to develop them."
Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to ongoing dialogue with our US partners on how subsequent co-operation could be structured in a manner that respects the independence and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but suggested that negotiations should continue considering a large portion of the nation's HIV programmes relied on international support.
"In cases where specific concerns exist, such as those involving information security or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," the group added.
The halted deal underscores the complex tensions between receiving much-needed foreign assistance and safeguarding national sovereignty in an increasingly data-driven world.